FT
BMY.RT

Fiduciary Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Fiduciary Trust’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-63,068
Closed -$43K – 614
2020
Q4 		$43K Sell
63,068
-6,108
-9% -$13K ﹤0.01% 568
2020
Q3 		$155K Sell
69,176
-3,155
-4% -$9.01K ﹤0.01% 537
2020
Q2 		$259K Sell
72,331
-501
-0.7% -$1.81K 0.01% 479
2020
Q1 		$277K Buy
72,832
+39,367
+118% +$130K 0.01% 429
2019
Q4 		$101K Buy
+33,465
New +$87K ﹤0.01% 511

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Fiduciary Trust's BMY.RT Position: Q1 2021 in Review

Fiduciary Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 63,068 shares — an estimated $43K sold.

Fiduciary Trust first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $277K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Fiduciary Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Fiduciary Trust sold 63,068 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $43K.
  • Fiduciary Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Fiduciary Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $277K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Fiduciary Trust's 13F filing for Q1 2021, filed 19 May 2021.